Showing 3461-3470 of 5689 results for "".
- Market Scope: Patient Demand for Better Vision Will Drive Double-Digit Growth in IOL Revenueshttps://modernod.com/news/patient-demand-for-better-vision-will-drive-double-digit-growth-in-iol-revenues/2480268/Technological innovations in premium IOLs will help drive global IOL revenues to more than $6.1 billion by 2023, according to Market Scope data.
- International Meta-Analysis Finds Higher-Dose Atropine Linked to Clinically Meaningful Accommodation Changes in Pediatric Myopia Controlhttps://modernod.com/news/international-meta-analysis-finds-higher-dose-atropine-linked-to-clinically-meaningful-accommodation-changes-in-pediatric-myopia-control/2487382/Key Takeaways A systematic review and meta-analysis of 13 randomized controlled trials found that atropine's effects on accommodation and binocular vision are dose-dependent
- Rayner Launches Optiesis Cohesive OVD Familyhttps://modernod.com/news/rayner-launches-optiesis-cohesive-ovd-family/2487302/Rayner announced the launch of Optiesis Cohesive, a proprietary new ophthalmic viscosurgical device (OVD), marking an expansion of its OVD portfolio and surgical product offering. According to the company, Optiesis Cohesive is
- Cure Blindness Project Releases 2025 Impact Report Highlighting Global Reach and Restored Visionhttps://modernod.com/news/cure-blindness-project-releases-2025-impact-report-highlighting-global-reach-and-restored-vision/2487240/Cure Blindness Project has released its 2025 Impact Report, detailing significant progress in expanding access to eye care and preventing avoidable blindness worldwide. The re
- Lumenis Expands Peer-to-Peer Education With 2026 Accelerate Series for Eye Care Professionalshttps://modernod.com/news/lumenis-expands-peer-to-peer-education-with-2026-accelerate-series-for-eye-care-professionals/2487031/Lumenis announced the launch of its 2026 Accelerate education series, a nationwide peer-to-peer learning initiative designed to help eye care professionals expand procedural services, strengthen clinical confidence, and integrate advanced therapeutic technologies in
- Ametek Reichert Expands Tele-Optometry Capabilities with SightChek Integration into DigitalOptometrics Platformhttps://modernod.com/news/ametek-reichert-expands-tele-optometry-capabilities-with-sightchek-integration-into-digitaloptometrics-platform/2486980/Key Takeaways Reichert SightChek Digital Phoroptor is now integrated with the DigitalOptometrics platform The in
- Johnson & Johnson Showcases New Vision Research at ARVO 2026https://modernod.com/news/johnson-johnson-showcases-new-vision-research-at-arvo-2026/2486943/Johnson & Johnson Vision is presenting a broad range of new clinical and preclinical data at the 2026 Association for Research in Vision and Ophthalmology (ARVO) annual meeting in Denver, highlighting advancements across IOLs, contact lenses, and myopia manageme
- Early Screening and Outdoor Activity Key to Tackling Childhood Myopia, Italian Study Findshttps://modernod.com/news/early-screening-and-outdoor-activity-key-to-tackling-childhood-myopia-italian-study-finds/2486939/Key Takeaways Early and regular eye screenings—starting around age 3—are critical for detecting and managing childhood myopia before it progresses
- Theialife Appoints Thomas Ruggia as President and CEOhttps://modernod.com/news/theialife-appoints-thomas-ruggia-as-president-and-ceo/2486807/Theialife announced the appointment of Thomas Ruggia as President and Chief Executive Officer. Mr. Ruggia will oversee the company’s development, operational, and corporate strategy as it approaches key milestones, including the planned initiation of phase 3 clinic
- Focus A-Eye to Launch Inaugural AI Summit Advancing the Future of Ophthalmologyhttps://modernod.com/news/focus-a-eye-to-launch-inaugural-ai-summit-advancing-the-future-of-ophthalmology/2486795/Focus A-Eye, a specialized medical education and innovation forum dedicated to advancing the application of AI in ophthalmology, has announced the launch of its inaugural Focus A-Eye Summit, set to take place on Saturday, May 2, 2026, in Denver, Colorado.